Blog y noticias


On February 23rd and 24th, the XII Veterinary Ophthalmology Congress was held in Madrid, organized by SEOVET (Spanish Society of Veterinary Ophthalmology).

This year, for the third consecutive time, Dr+Vet is once again sponsoring the largest Spanish congress of veterinary ophthalmology, the SEOVET. More than 140 specialists in this field gathered to share impressions and learn from great specialists.

This year the pre-congress started on Friday with the presentation of Laura Muñoz (Founder and Medical Director of OCULARVET). This was followed by the first lecture on photography in ophthalmology given by Javier Esteban of Anicura Ocaña and then the second lecture on photography given by Raquel Udiz. Both talks provided the attending veterinarians with interesting tips to improve their imaging technique and clinical data collection.

In the afternoon the congress started with a lot of enthusiasm from all participants and attendees. During the SEOVET we could enjoy presentations given by Eva Abarca (HV Canis de Mallorca), Manolo Villagrasa (COV, HV Puchol de Madrid), Màrian Matas (Memvet de Palma), Paco Simó (IVO de Barcelona), Ángel Ortillés (Anicura Valencia Sur de Valencia) and Fernando Sanz (Visionvet de Sevilla).

The SEOVET management knew how to organize a truly dynamic, educational and entertaining conference where all veterinarians could learn the latest developments in their field and at the same time fully enjoy the company and gastronomy.

Dr+Vet had the opportunity to present directly to a specialized audience the improved version of our products GLAUCO+ and OCCULUS+.


One of our presentations was Glauco+, a nutritional supplement designed to address the progression of glaucoma in pets. The improved formula, which includes neuroprotective and vasodilator components in addition to citicoline, has attracted a great deal of interest from ophthalmology veterinarians who had long been asking for this improvement over the Glauco formula.


We also share the improvements in Occulus+. With the addition of key nutritional elements and an improved formulation with alpha lipoic acid, Occulus+ reinforces its antioxidant effect on the crystalline lens.

This year at Dr+Vet we have no plans to put on the brakes, so we are already looking forward to the next big event: Iberzoo+Propet. See you again at IFEMA Madrid from March 13-15!


Last week, the Dr+Vet team participated in the AVEPA SEVC congress, where we exchanged opinions and learned from high-level clinical veterinarians and at the same time we were able to share with them the novelties in our catalog:


One of our presentations was Glauco+, a nutritional supplement designed to address the progression of glaucoma in pets. The improved formula, which includes natural components and, most importantly, citicoline, has aroused great interest among ophthalmology veterinarians who had long been asking for this improvement over the Glauco formula.


In our participation in AVEPA SEVC, we also shared the improvements in Occulus+. With the addition of key nutritional elements and an improved formulation, Occulus+ reinforces its antioxidant effect in crystalline lens.

The response we received from the veterinarians who visited our booth was certainly inspiring. It fills us with gratitude to see how our products are received with enthusiasm and appreciation by professionals committed to animal welfare.

We thank all the veterinarians who came by, shared their perspectives and were part of this enriching experience.

See you at AVEPA-SEVC Madrid 2024!


Dr+Vet will participate in AVEPA-SEVC 2023, the leading event in the field of general veterinary medicine, which will take place in Barcelona from November 9-11.

During these days we will have the opportunity to connect with professionals from all over the veterinary sector and share our latest innovations in veterinary nutraceuticals.

During this congress we will present our improved formulas in the ophthalmological gamma: Glauco+ and Occulus+. Two products that have been part of Dr+Vet since its inception now receive a plus in composition, adapting to new trends and scientific evidence.

Glauco+: Nutritional Support for Glaucoma
Our Glauco+ product has been enhanced with the addition of citicoline, offering essential nutritional support for pets suffering from glaucoma. By providing nutrients to the retina and optic nerve, Glauco+ aims to aid in neuroprotection in cases of normotensive glaucoma.

Occulus+: Improving Lens Health
Occulus+, with abundant antioxidants in its formula, now features the benefits of alpha lipoic acid, enriching the formula to help animals with cataracts and support overall lens health.

Other product lines
In addition to our ophthalmological line, we will also provide detailed information on our digestive and metabolic gammas, with Glyco, Flavum, Digestum and Colitum products.

AVEPA-SEVC 2023 serves as a platform to interact with professional colleagues and showcase our commitment to innovative veterinary care. Our team will be available to provide detailed information and answer any questions you may have about our products.

Stay tuned for updates and follow us on social media for more details as the event approaches – see you there!
For more information about AVEPA-SEVC 2023, visit the official event website:


From Dr+Vet we are pleased to announce our improvement in the formula of our classic Glauco, the veterinary nutraceutical focused to provide nutrients to the retina and offer neuroprotection to the optic nerve to prevent its degeneration, very relevant in cases of Glaucoma.

Glaucoma is a progressive optic retinopathy and one of the major causes of blindness in humans, it is characterized by optic nerve degeneration, loss of retinal ganglion cells (RGC) and cause restructuring of nerve tissues, causing visual loss.
The factors causing this condition are diverse and complex. Increased intraocular pressure (IOP) has been identified as one of the main drivers of glaucoma and is also the mainstay in the treatment of this disease, focusing on topical and systemic IOP-lowering treatments. Although even though IOP can be effectively controlled, there are patients whose disease still progresses, causing irreversible vision loss.
It is for this reason that Dr+Vet created Glauco+, a nutritional supplement with several natural components that help to generate positive effects on the retina and offer protection against the progression of this disease. Through the incorporation of Citicoline, a molecule that has demonstrated its potential in studies on neurodegenerative diseases, we are opening a door towards a more complete approach to the management of glaucoma in our pets.

Discovering the Potential of Citicoline
In the constant quest to improve treatments for glaucoma in pets, ophthalmic specialists have played a key role in the evolution of therapeutic options. It is for this reason that the incorporation of citicoline in the Glauco+ formula has been a long-awaited and much-requested addition by these eye health experts. Citicoline has garnered considerable attention in the field of neurodegenerative diseases. Research in human medicine has shown its potential benefits in conditions such as senile dementia, Parkinson’s disease and glaucoma. Its introduction in Glauco+ aims to take advantage of these potential benefits for pets.

Citicoline, also known as cytidine-5′-diphosphocholine, is essential for synthesizing membrane phospholipids, including phosphatidylcholine. This compound participates in several metabolic pathways, playing roles in phospholipid homeostasis, mitochondrial dynamics and neurotransmission, especially in the complex mechanism of visual transmission.
When administered orally, Citicoline is efficiently absorbed in the intestines, being transformed into choline and cytidine in the digestive tract and liver. These compounds cross the blood-brain barrier, becoming precursors of vital metabolites. These include phospholipids, nucleic acids, proteins, sphingomyelin, cardiolipin and acetylcholine, a major neurotransmitter in the cholinergic system that modulates visual processes.
In human clinical studies, the ability of citicoline to counteract glutamate-mediated excitotoxicity and oxidative stress, factors that play a crucial role in glaucoma-associated neuronal damage, has been observed. In addition, its influence on the regulation of neurotransmitters such as dopamine and acetylcholine has been linked to improvements in visual function, which translates into a positive impact on quality of life.

Not only has citicoline been shown to protect damaged retinal ganglion cells, but it also acts to improve mitochondrial function and cell membrane integrity. These effects are particularly relevant in the context of glaucoma, where mitochondrial aging processes and neuronal axon damage are characteristic features of the disease.

The classic Glauco components are still present
The Glauco+ approach is based on the combination of natural components, each with its own unique properties and benefits. These components have been selected to address multiple factors, providing a comprehensive solution.
Ginkgo biloba: Native to Asia, this medicinal plant has been appreciated for its properties in traditional medicine for centuries. The extracts of its leaves are rich in flavonoids and terpenoids, which have shown beneficial effects on blood circulation, reduction of blood viscosity, increase in retinal blood flow and neuroprotection.
Anthocyanins (Vaccinium myrtillus, wild blueberry): These natural pigments, present in fruits and vegetables, help improve blood circulation and show antioxidant action. They have an affinity for vascular tissues and have been recognized as beneficial for eye health. Anthocyanins have been shown to contribute to the normalization of retinal blood flow.
Vitamin B3 (Niacinamide or Nicotinamide): This essential vitamin acts as a precursor to the coenzyme nicotinamide adenine dinucleotide (NAD+), vital for mitochondrial function and energy production in retinal ganglion cells. The decrease in NAD+ levels with age and in neurodegenerative diseases, such as glaucoma, has been documented. Supplementation with vitamin B3 has been shown to be a powerful neuroprotectant, preventing neuronal damage and mitochondrial dysfunction.
Vitamin B9 (folic acid) and Vitamin B12 – These B vitamins play a key role in regulating levels of homocysteine, an amino acid linked to retinal damage. The relationship between elevated homocysteine levels and eye damage has been highlighted in several studies. Taking vitamins B12 and B9, in particular, has been associated with reducing homocysteine levels, which could be beneficial in preventing this form of damage.

New tablet format divisible into 4 parts
With the new format divisible into 4 parts, we offer the possibility of adjusting the dose of Glauco+ according to the individual needs of each pet. This new format makes dosing more personalized and precise than with the old format. Offering the possibility of dosing from 2.5kg onwards.
How to get Glauco+?
To purchase Glauco+, you can obtain it exclusively through veterinary distributors in specialized clinics. This measure guarantees that you receive the product under the guidance and supervision of animal health professionals.

In summary
The inclusion of citicoline in Glauco+ represents a step forward in the search for more complete dietary supplements for the eye health of pets. The support and recommendation of ophthalmologists specialized in ocular health are the basis for the development of new and improved products focused especially on veterinary medicine.

From Dr+Vet we want to remember that Glauco+ will be available from November and that at AVEPA-SEVC we will be presenting the product.

Copyright by Boothmen Pharma 2023. All rights reserved.